IVF HARTMANN Holding AG Logo

IVF HARTMANN Holding AG

Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.

VBSN | SW

Overview

Corporate Details

ISIN(s):
CH0187624256
LEI:
Country:
Switzerland
Address:
Victor-von-Bruns-Strasse 28, 8212 Neuhausen am Rheinfall
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

IVF HARTMANN Holding AG is a Swiss-based holding company engaged in the production and distribution of medical supplies and consumer goods. As a leading manufacturer in Switzerland for over 150 years, the company serves as a key supplier to the national healthcare industry. Its product portfolio includes a wide range of medical, pharmaceutical, and hygiene items, such as wound care dressings, bandages, surgical disposables, first-aid supplies, and accident prevention products. The company provides these essential goods to both the Swiss market and internationally.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IVF HARTMANN Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IVF HARTMANN Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IVF HARTMANN Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-08-23 N/A Non-Executive member Buy None 11,200.00 CHF
2023-08-21 N/A Non-Executive member Buy None 11,200.00 CHF

Peer Companies

Company Country Ticker View
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530
PROTIA INC. Logo
Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.
South Korea 303360

Talk to a Data Expert

Have a question? We'll get back to you promptly.